50 reports

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

399 pages • By TriMark Publications

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred....

2 720 3 400 2 176
Jan 2014

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel

151 pages • By Allied Market Research

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020Biomarkers...

3 612 4 515 2 890
Dec 2013

Global Imaging Biomarkers Market 2014-2018

49 pages • By Infiniti Research Limited

TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the...

1 600 2 000 1 280
Nov 2013

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

350 pages • By Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline,...

3 600 4 500 2 880
Nov 2013

Molecular Diagnostics in Cancer Testing

232 pages • By TriMark Publications

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics,...

2 720 3 400 2 176
Nov 2013

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

327 pages • By MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018) A biomarker is an identifiable and measurable characteristic, which...

3 720 4 650 2 976
Sep 2013

Companion Biomarkers in Drug Development

356 pages • By TriMark Publications

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid...

2 720 3 400 2 176
Aug 2013

Biomarkers: Technological and Commercial Outlook 2013-2023

178 pages • By Visiongain

Report DetailsBiomarkers - how to find R&D trends and potential salesWhat's the outlook for biomarkers? Visiongain's updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities.That study gives you revenue forecasts to 2023 at overall...

2 141 2 633 1 691
Jul 2013

ACS Biomarker - Medical Equipment - Deals and Alliances Profile

12 pages • By Global Data

SummaryACS Biomarker is a phramaceutical and healthcare company engaged in the discovery and development biomarkers that help in improving prognosis and management of cardiac disease. The company is based in Maastricht, Netherlands.ACS Biomarker - Medical Equipment - Deals and Alliances Profile provides you comprehensive...

200 250 160
Jul 2013

BioMarker Strategies, LLC - Medical Equipment - Deals and Alliances Profile

16 pages • By Global Data

SummaryBioMarker Strategies, LLC (BioMarker Strategies) is a tissue-based cancer diagnostics company. The company's product SnapPath, a novel automated tumor biopsy processing and testing system, is used to quickly test and analyze a patient’s live solid tumor sample at the point of biopsy. In addition to generating traditional...

200 250 160
Jul 2013

Pacific Biomarkers, Inc. (GPCM) - Financial and Strategic SWOT Analysis Review

25 pages • By Global Data

SummaryThis comprehensive SWOT profile of Pacific Biomarkers, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats....

240 300 192
Jul 2013

PharmaFocus: Biomarkers in Alzheimer’s Disease

179 pages • By Global Data

PharmaFocus: Biomarkers in Alzheimer’s Disease SummaryAlzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The disease has emerged as a major global health priority especially because of its rapidly accelerating...

3 196 3 995 2 557
Jun 2013

Personalized Medicine Market Analysis

90 pages • By RNCOS

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular...

960 1 200 768
May 2013

Advances in Disease Theranostics (Technical Insights)

By Frost & Sullivan

This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective.

4 792 5 990 3 834
May 2013

Cancer Diagnostic Testing World Markets

336 pages • By TriMark Publications

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than...

2 720 3 400 2 176
May 2013

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

153 pages • By BCC Research

REPORT SCOPEINTRODUCTIONBiomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, indicate what treatment options may be most effective in an individual patient’s case and predict treatment response. They play a role both in...

5 320 6 650 4 256
Mar 2013

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

87 pages • By GBI Research

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes SummaryGBI Research’s new report, “Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes” provides information and...

2 800 3 500 2 240
Nov 2012

Mass Spectroscopy for Clinical Laboratory Analysis

165 pages • By TriMark Publications

Mass spectroscopy is a clinical laboratory analysis technique used in determining the basic composition and structure of a sample or molecule. The process involves bending a charged beam of vaporized material using an electric and/or magnetic field and then plotting a spectrum of how the sample's ions are deflected. Mass spectroscopy assays...

2 720 3 400 2 176
Nov 2011

Pacific Biomarkers, Inc. (formerly Pacific Biometrics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

By MarketLine

Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.Project Description:Datamonitors' Pacific...

280 350 224
Sep 2011

Commercializing Biomarkers in Therapeutic and Diagnostic Applications - Overview

By CHI Insight Pharma Reports

Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing knowledge about biomarkers and successfully commercialize them in therapeutic and diagnostic applications. Included in this publication:...

2 556 3 195 2 045
May 2011